Tags

Type your tag names separated by a space and hit enter

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
Trends Neurosci. 2020 06; 43(6):355-357.TN

Abstract

Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), can cause neurological complications. We provide a brief overview of these recent observations and discuss some of their possible implications. In particular, given the global dimension of the current pandemic, we highlight the need to consider the possible long-term impact of COVID-19, potentially including neurological and neurodegenerative disorders.

Links

Publisher Full Text
ncbi.nlm.nih.gov
linkinghub.elsevier.com
PMC Free PDF
Aggregator Full Text

Authors+Show Affiliations

De Felice FG
Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brazil; Centre for Neuroscience Studies, Queen's University, Kingston, ON K7L 3N6, Canada; Department of Psychiatry, Queen's University, Kingston, ON K7L 3N6, Canada. Electronic address: felice@bioqmed.ufrj.br.
Tovar-Moll F
Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brazil; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
Moll J
D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.
Munoz DP
Centre for Neuroscience Studies, Queen's University, Kingston, ON K7L 3N6, Canada.
Ferreira ST
Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brazil; Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brazil.

MeSH

AnimalsBetacoronavirusCOVID-19Central Nervous SystemCoronavirus InfectionsHumansNervous System DiseasesPandemicsPneumonia, ViralSARS-CoV-2

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32359765

Citation

De Felice, Fernanda G., et al. "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System." Trends in Neurosciences, vol. 43, no. 6, 2020, pp. 355-357.
De Felice FG, Tovar-Moll F, Moll J, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends Neurosci. 2020;43(6):355-357.
De Felice, F. G., Tovar-Moll, F., Moll, J., Munoz, D. P., & Ferreira, S. T. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends in Neurosciences, 43(6), 355-357. https://doi.org/10.1016/j.tins.2020.04.004
De Felice FG, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends Neurosci. 2020;43(6):355-357. PubMed PMID: 32359765.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. AU - De Felice,Fernanda G, AU - Tovar-Moll,Fernanda, AU - Moll,Jorge, AU - Munoz,Douglas P, AU - Ferreira,Sergio T, Y1 - 2020/04/21/ PY - 2020/04/12/received PY - 2020/04/14/accepted PY - 2020/5/4/pubmed PY - 2020/6/6/medline PY - 2020/5/4/entrez KW - COVID-19 KW - Parkinson’s disease KW - anosmia KW - encephalitis KW - neurodegenerative diseases KW - neurological alterations SP - 355 EP - 357 JF - Trends in neurosciences JO - Trends Neurosci VL - 43 IS - 6 N2 - Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), can cause neurological complications. We provide a brief overview of these recent observations and discuss some of their possible implications. In particular, given the global dimension of the current pandemic, we highlight the need to consider the possible long-term impact of COVID-19, potentially including neurological and neurodegenerative disorders. SN - 1878-108X UR - https://www.unboundmedicine.com/medline/citation/32359765/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S0166-2236(20)30091-6 DB - PRIME DP - Unbound Medicine ER -